Ajax loader

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Genomics

NIGERIA-FOOD/YAM
RTSAA0WD 
August 02, 2022 
Dr. Ranjana Bhattacharjee, a molecular geneticist at the International Institute of Tropical Agriculture,... 
Ibadan, Nigeria 
Dr. Ranjana Bhattacharjee, a molecular geneticist at the International Institute of Tropical Agriculture,... 
Dr. Ranjana Bhattacharjee, a molecular geneticist at the International Institute of Tropical Agriculture, sequences yam genomes at the Laboratory in Ibadan, Oyo, Nigeria August 2, 2022. REUTERS/Temilade Adelaja 
NIGERIA-FOOD/YAM
RTSAA0V6 
August 02, 2022 
Vials containing yam samples for genome sequencing are pictured in the laboratory at the International... 
Ibadan, Nigeria 
Vials containing yam samples for genome sequencing are pictured in the laboratory at the International... 
Vials containing yam samples for genome sequencing are pictured in the laboratory at the International Institute of Tropical Agriculture in Ibadan, Oyo, Nigeria August 2, 2022. REUTERS/Temilade Adelaja 
NIGERIA-FOOD/YAM
RTSAA0TD 
August 02, 2022 
Dr. Ranjana Bhattacharjee, a molecular geneticist at the International Institute of Tropical Agriculture,... 
Ibadan, Nigeria 
Dr. Ranjana Bhattacharjee, a molecular geneticist at the International Institute of Tropical Agriculture,... 
Dr. Ranjana Bhattacharjee, a molecular geneticist at the International Institute of Tropical Agriculture, sequences yam genomes at the laboratory in Ibadan, Oyo, Nigeria August 2, 2022. REUTERS/Temilade Adelaja 
MILKEN-CONFERENCE/
RTS7K0KZ 
May 03, 2022 
Alice Zhang, CEO and Co-Founder at Verge Genomics speaks at the 2022 Milken Institute Global Conference... 
Beverly Hills, UNITED STATES 
2022 Milken Institute Global Conference 
Alice Zhang, CEO and Co-Founder at Verge Genomics speaks at the 2022 Milken Institute Global Conference in Beverly Hills, California, U.S., May 3, 2022. REUTERS/Mike Blake 
MILKEN-CONFERENCE/
RTS7K0EI 
May 03, 2022 
Alice Zhang, CEO and Co-Founder of Verge Genomics, speaks at the 2022 Milken Institute Global Conference... 
Beverly Hills, UNITED STATES 
2022 Milken Institute Global Conference 
Alice Zhang, CEO and Co-Founder of Verge Genomics, speaks at the 2022 Milken Institute Global Conference in Beverly Hills, California, U.S., May 3, 2022. REUTERS/Mike Blake 
HEALTH-CORONAVIRUS/OMICRON
RTS3SX9X 
December 16, 2021 
Andrew Marques, a graduate student at the Penn Center for Research on Coronavirus and Other Emerging... 
Philadelphia, UNITED STATES 
Coronavirus variant sequencing at the University of Pennsylvania 
Andrew Marques, a graduate student at the Penn Center for Research on Coronavirus and Other Emerging Pathogens, measures the concentration of positive SARS-CoV-2 genome samples at the University of Pennsylvania’s Perelman School of Medicine in Philadelphia, Pennsylvania, U.S., December 16, 2021. REUTERS/Hannah Beier 
HEALTH-CORONAVIRUS/OMICRON
RTS3SX9V 
December 16, 2021 
Andrew Marques, a graduate student at the Penn Center for Research on Coronavirus and Other Emerging... 
Philadelphia, UNITED STATES 
Coronavirus variant sequencing at the University of Pennsylvania 
Andrew Marques, a graduate student at the Penn Center for Research on Coronavirus and Other Emerging Pathogens, prepares for SARS-CoV-2 genome sequencing at the University of Pennsylvania’s Perelman School of Medicine in Philadelphia, Pennsylvania, U.S., December 16, 2021. REUTERS/Hannah Beier 
HEALTH-CORONAVIRUS/OMICRON
RTS3SX9S 
December 16, 2021 
Andrew Marques, a graduate student at the Penn Center for Research on Coronavirus and Other Emerging... 
Philadelphia, UNITED STATES 
Coronavirus variant sequencing at the University of Pennsylvania 
Andrew Marques, a graduate student at the Penn Center for Research on Coronavirus and Other Emerging Pathogens, prepares to measure the concentration of positive SARS-CoV-2 genome samples at the University of Pennsylvania’s Perelman School of Medicine in Philadelphia, Pennsylvania, U.S., December 16, 2021. REUTERS/Hannah Beier 
HEALTH-CORONAVIRUS/OMICRON
RTS3SX9T 
December 16, 2021 
Andrew Marques, a graduate student at the Penn Center for Research on Coronavirus and Other Emerging... 
Philadelphia, UNITED STATES 
Coronavirus variant sequencing at the University of Pennsylvania 
Andrew Marques, a graduate student at the Penn Center for Research on Coronavirus and Other Emerging Pathogens, prepares to measure the concentration of positive SARS-CoV-2 genome samples at the University of Pennsylvania’s Perelman School of Medicine in Philadelphia, Pennsylvania, U.S., December 16, 2021. REUTERS/Hannah Beier 
HEALTH-CORONAVIRUS/WHO-CHINA
RTXB0R6S 
March 31, 2021 
Yang Yungui, professor at Beijing Institute of Genomics of the Chinese Academy of Sciences, attends a... 
Beijing, China 
Yang Yungui at a news conference on the WHO-China joint study, in Beijing 
Yang Yungui, professor at Beijing Institute of Genomics of the Chinese Academy of Sciences, attends a news conference on the WHO-China joint study on the origins of the coronavirus disease (COVID-19), in Beijing, China March 31, 2021. REUTERS/Thomas Suen 
HEALTH-CORONAVIRUS/WHO-CHINA
RTXB0QNQ 
March 31, 2021 
National Health Commission spokesman Mi Feng, Tong Yigang, professor at Beijing University of Chemical... 
Beijing, China 
News conference on the WHO-China joint study, in Beijing 
National Health Commission spokesman Mi Feng, Tong Yigang, professor at Beijing University of Chemical Technology, Liang Wannian, co-leader of the WHO-China joint expert team, Feng Zijian, deputy director of Chinese Center for Disease Control and Prevention, and Yang Yungui, professor at Beijing Institute of Genomics of the Chinese Academy of Sciences, attend a news conference on the WHO-China joint study on the origins of the coronavirus disease (COVID-19), in Beijing, China March 31, 2021. REUTERS/Thomas Suen 
HEALTH-CHINA/BGI-DNA
RTXE3CJC 
March 23, 2021 
A view of the signage on a building of Bangkok Genomics Innovation, a local subsidiary of Chinese gene... 
Bangkok, Thailand 
To match Special Report HEALTH-CHINA/BGI-DNA 
A view of the signage on a building of Bangkok Genomics Innovation, a local subsidiary of Chinese gene firm BGI Group, in Bangkok, Thailand, March 23, 2021. Picture taken March 23, 2021. REUTERS/Chalinee Thirasupa To match Special Report HEALTH-CHINA/BGI-DNA 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2RL 
March 15, 2021 
Used vials are seen at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics... 
Cambridge, United Kingdom 
Used vials are seen at a laboratory where they sequence the novel coronavirus genomes in Cambridge 
Used vials are seen at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2RK 
March 15, 2021 
Used vials are seen at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics... 
Cambridge, United Kingdom 
Used vials are seen at a laboratory where they sequence the novel coronavirus genomes in Cambridge 
Used vials are seen at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2OF 
March 15, 2021 
A scientist checks a vial containing positive samples of the novel coronavirus at a laboratory where... 
Cambridge, United Kingdom 
A scientist checks a vial containing positive samples of the novel coronavirus at a laboratory in Cambridge... 
A scientist checks a vial containing positive samples of the novel coronavirus at a laboratory where they sequence the virus' genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2OD 
March 15, 2021 
A scientist checks a vial containing positive samples of the novel coronavirus at a laboratory where... 
Cambridge, United Kingdom 
A scientist checks a vial containing positive samples of the novel coronavirus at a laboratory in Cambridge... 
A scientist checks a vial containing positive samples of the novel coronavirus at a laboratory where they sequence the virus' genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2OE 
March 15, 2021 
A scientist shakes vials containing positive samples of the novel coronavirus at a laboratory where they... 
Cambridge, United Kingdom 
A scientist shakes vials containing positive samples of the novel coronavirus at a laboratory in Cambridge... 
A scientist shakes vials containing positive samples of the novel coronavirus at a laboratory where they sequence the virus' genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2IZ 
March 15, 2021 
A sign is seen for the laboratories where they sequence the novel coronavirus genomes at COVID-19 Genomics... 
Cambridge, United Kingdom 
A sign is seen for the laboratories where they sequence the novel coronavirus genomes in Cambridge 
A sign is seen for the laboratories where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2IX 
March 15, 2021 
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics... 
Cambridge, United Kingdom 
Scientists work at a laboratory where they sequence the novel coronavirus genomes in Cambridge 
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2IY 
March 15, 2021 
A sign is seen for the laboratories where they sequence the novel coronavirus genomes at COVID-19 Genomics... 
Cambridge, United Kingdom 
A sign is seen for the laboratories where they sequence the novel coronavirus genomes in Cambridge 
A sign is seen for the laboratories where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2FR 
March 15, 2021 
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics... 
Cambridge, United Kingdom 
Scientists work at a laboratory where they sequence the novel coronavirus genomes in Cambridge 
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2FQ 
March 15, 2021 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome... 
Cambridge, United Kingdom 
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2FS 
March 15, 2021 
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics... 
Cambridge, United Kingdom 
Scientists work at a laboratory where they sequence the novel coronavirus genomes in Cambridge 
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2DJ 
March 15, 2021 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome... 
Cambridge, United Kingdom 
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2DI 
March 15, 2021 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome... 
Cambridge, United Kingdom 
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2DD 
March 15, 2021 
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics... 
Cambridge, United Kingdom 
Scientists work at a laboratory where they sequence the novel coronavirus genomes in Cambridge 
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2DB 
March 15, 2021 
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics... 
Cambridge, United Kingdom 
Scientists work at a laboratory where they sequence the novel coronavirus genomes in Cambridge 
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2A5 
March 15, 2021 
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics... 
Cambridge, United Kingdom 
Scientists work at a laboratory where they sequence the novel coronavirus genomes in Cambridge 
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2A6 
March 15, 2021 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome... 
Cambridge, United Kingdom 
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2A4 
March 15, 2021 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome... 
Cambridge, United Kingdom 
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2A3 
March 15, 2021 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome... 
Cambridge, United Kingdom 
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG27S 
March 15, 2021 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome... 
Cambridge, United Kingdom 
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG27Q 
March 15, 2021 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome... 
Cambridge, United Kingdom 
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG24D 
March 15, 2021 
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics... 
Cambridge, United Kingdom 
Scientists work at a laboratory where they sequence the novel coronavirus genomes in Cambridge 
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG24E 
March 15, 2021 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome... 
Cambridge, United Kingdom 
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG1YK 
March 15, 2021 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome... 
Cambridge, United Kingdom 
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge 
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez 
CHINA-GENES/AGEING
RTX8NJU6 
January 20, 2021 
Dr. Jing Qu (R), team leader for Stem Cell and Ageing group, and Dr. Wei Wang discuss the work on genome-wide... 
Beijing, China 
Researchers work at the Institute for Stem Cell and Regeneration of CAS in Beijing 
Dr. Jing Qu (R), team leader for Stem Cell and Ageing group, and Dr. Wei Wang discuss the work on genome-wide screen for novel ageing regulatory genes in human stem cells at the cell culture room of the Aging and Regeneration lab at the Institute for Stem Cell and Regeneration of the Chinese Academy of Sciences (CAS) in Beijing, China, January 12, 2021. Picture taken January 12, 2021. REUTERS/Tingshu Wang 
HEALTH-CORONAVIRUS/EVOLUTION C
RTX8FDRE 
December 11, 2020 
The mutations that give rise to new strains occur when the SARS-CoV-2 virus makes copies of itself inside... 
Genome mutation of the novel coronavirus C 
The mutations that give rise to new strains occur when the SARS-CoV-2 virus makes copies of itself inside a new host. The virus’ genome is a complete set of genetic instructions that is written in 30,000 “letters” of code. 
HEALTH-CORONOVIRUS/EVOLUTION C
RTX8F78N 
December 10, 2020 
Reuters analysed over 185,000 genome samples from GISAID, the largest database of novel coronavirus genome... 
Shifting strains of the novel coronavirus C 
Reuters analysed over 185,000 genome samples from GISAID, the largest database of novel coronavirus genome sequences in the world, to show how the regional dominance of major strains has shifted over time. 
NOBEL-PRIZE/CHEMISTRY
RTX8EL7A 
December 07, 2020 
French scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in... 
Berlin, Germany 
French scientist Emmanuelle Charpentier receives her Nobel medal at the Swedish Ambassador’s residence... 
French scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin, 2020 Nobel Prize winner in Chemistry for the development of a method for genome editing, poses after receiving her Nobel diploma and medal from Per Thoresson, Swedish Ambassador to Germany, at the Swedish Ambassador’s residence in Berlin, Germany December 7, 2020. John Macdougall/Pool via REUTERS 
NOBEL-PRIZE/CHEMISTRY
RTX8EL6W 
December 07, 2020 
French scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in... 
Berlin, Germany 
French scientist Emmanuelle Charpentier receives her Nobel medal at the Swedish Ambassador’s residence... 
French scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin, 2020 Nobel Prize winner in Chemistry for the development of a method for genome editing, poses after receiving her Nobel diploma and medal from Per Thoresson, Swedish Ambassador to Germany, at the Swedish Ambassador’s residence in Berlin, Germany December 7, 2020. John Macdougall/Pool via REUTERS 
NOBEL-PRIZE/CHEMISTRY
RTX8EL6Q 
December 07, 2020 
French scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in... 
Berlin, Germany 
French scientist Emmanuelle Charpentier poses with her Nobel medal at the Swedish Ambassador’s residence... 
French scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin, 2020 Nobel Prize winner in Chemistry for the development of a method for genome editing, poses with her Nobel medal at the Swedish Ambassador?s residence in Berlin, Germany December 7, 2020. John Macdougall/Pool via REUTERS 
NOBEL-PRIZE/CHEMISTRY
RTX8EL6O 
December 07, 2020 
French scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in... 
Berlin, Germany 
French scientist Emmanuelle Charpentier poses with her Nobel medal at the Swedish Ambassador’s residence... 
French scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin, 2020 Nobel Prize winner in Chemistry for the development of a method for genome editing, poses with her Nobel medal at the Swedish Ambassador’s residence in Berlin, Germany December 7, 2020. John Macdougall/Pool via REUTERS 
HEALTH-CORONAVIRUS/INDIA-CASES
RTX88RV0 
November 11, 2020 
Debojyoti Chakraborty, Senior Scientist, at the Council of Scientific and Industrial Research (CSIR)... 
New Delhi, India 
Debojyoti Chakraborty shows the coronavirus disease (COVID-19) tests results done by 'Feluda' paper strips... 
Debojyoti Chakraborty, Senior Scientist, at the Council of Scientific and Industrial Research (CSIR) Institute of Genomics and Integrative Biology, shows the coronavirus disease (COVID-19) tests results done by 'Feluda' paper strips based test developed by CSIR, in New Delhi, India, November 11, 2020. REUTERS/Adnan Abidi 
NOBEL-PRIZE/CHEMISTRY
RTX80KX8 
October 07, 2020 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Berlin, Germany 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin poses after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch 
NOBEL-PRIZE/CHEMISTRY
RTX80KX7 
October 07, 2020 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Berlin, Germany 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin reacts after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch 
NOBEL-PRIZE/CHEMISTRY
RTX80KVB 
October 07, 2020 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Berlin, Germany 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin holds a Swedish themed puppet after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch TPX IMAGES OF THE DAY 
NOBEL-PRIZE/CHEMISTRY
RTX80KV3 
October 07, 2020 
Max Planck Institute for Infection Biology in Berlin where scientist Emmanuelle Charpentier, director... 
Berlin, Germany 
Max Planck Institute for Infection Biology in Berlin where scientist Emmanuelle Charpentier, director... 
Max Planck Institute for Infection Biology in Berlin where scientist Emmanuelle Charpentier, director of the Institute, has her office and laboratory, is seen, after she won the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch 
NOBEL-PRIZE/CHEMISTRY
RTX80KV0 
October 07, 2020 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Berlin, Germany 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin holds a swedish themed puppet after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch 
NOBEL-PRIZE/CHEMISTRY
RTX80KUU 
October 07, 2020 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Berlin, Germany 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin poses after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch 
NOBEL-PRIZE/CHEMISTRY
RTX80KUT 
October 07, 2020 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Berlin, Germany 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin holds a swedish themed puppet after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch 
NOBEL-PRIZE/CHEMISTRY
RTX80KUR 
October 07, 2020 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Berlin, Germany 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin holds a swedish themed puppet after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch 
NOBEL-PRIZE/CHEMISTRY
RTX80KUS 
October 07, 2020 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Berlin, Germany 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin reacts after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch 
NOBEL-PRIZE/CHEMISTRY
RTX80KUP 
October 07, 2020 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Berlin, Germany 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin puts on a protective face mask, after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch 
NOBEL-PRIZE/CHEMISTRY
RTX80KUJ 
October 07, 2020 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Berlin, Germany 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin puts on a protective face mask, after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch 
NOBEL-PRIZE/CHEMISTRY
RTX80KUI 
October 07, 2020 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Berlin, Germany 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin puts on a protective face mask, after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch 
NOBEL-PRIZE/CHEMISTRY
RTX80KU0 
October 07, 2020 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Berlin, Germany 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin poses after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch 
NOBEL-PRIZE/CHEMISTRY
RTX80KTZ 
October 07, 2020 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Berlin, Germany 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin poses after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch 
NOBEL-PRIZE/CHEMISTRY
RTX80KSY 
October 07, 2020 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Berlin, Germany 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin reacts after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch 
NOBEL-PRIZE/CHEMISTRY
RTX80KSX 
October 07, 2020 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Berlin, Germany 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin... 
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin poses after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch 
Sort by 
Display 
Items per page 
Page 
of 7